PROomics: Patient Reported Outcome (PRO) and Self-Tracking for Personalized Medicine
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".
Deadline for manuscript submissions: closed (15 August 2020) | Viewed by 21670
Special Issue Editor
Interests: behavioral health; physical activity; substance use; mobile health; technology; games for health; tobacco; alcohol; positive psychology; mindfulness
Special Issue Information
Dear Colleagues,
What is more personalized than including individual observations, personal feelings, and mood, as well as self-tracked data into the medical decision process? Individual observations, personal feelings, and mood constitute the so-called Patient-Reported Outcome (PRO). In daily life, we are facing a constantly growing number of PRO measurements based on digital applications. At the same time, the amount of medically useful data coming from self-tracking or wearable devices is rapidly increasing as well. PRO and self-tracking data represent a new class of medically valuable data. We have named them PROomics. As there are few or nearly no models on how to incorporate PROomics information into personalized medicine, we would like to invite researchers working in this field to submit their manuscripts to this Special Issue. PROomics means looking at patients’ documented and recorded data beyond a single questionnaire and making them available for research and medical care. Manuscripts of interest can range from basic research to clinical routine.
Dr. Beth C. Bock
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PRO
- ePRO
- PROM
- self-tracking
- self-tracking devices
- wearables
- big data
- medical APPs
- cloud medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.